Nature Communications (May 2017)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

  • Juan Pablo Lopez,
  • Laura M. Fiori,
  • Cristiana Cruceanu,
  • Rixing Lin,
  • Benoit Labonte,
  • Hannah M. Cates,
  • Elizabeth A. Heller,
  • Vincent Vialou,
  • Stacy M. Ku,
  • Christophe Gerald,
  • Ming-Hu Han,
  • Jane Foster,
  • Benicio N. Frey,
  • Claudio N. Soares,
  • Daniel J. Müller,
  • Faranak Farzan,
  • Francesco Leri,
  • Glenda M. MacQueen,
  • Harriet Feilotter,
  • Kathrin Tyryshkin,
  • Kenneth R. Evans,
  • Peter Giacobbe,
  • Pierre Blier,
  • Raymond W. Lam,
  • Roumen Milev,
  • Sagar V. Parikh,
  • Susan Rotzinger,
  • Steven C. Strother,
  • Cathryn M. Lewis,
  • Katherine J. Aitchison,
  • Gayle M. Wittenberg,
  • Naguib Mechawar,
  • Eric J. Nestler,
  • Rudolf Uher,
  • Sidney H. Kennedy,
  • Gustavo Turecki

DOI
https://doi.org/10.1038/ncomms15497
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 12

Abstract

Read online

Antidepressant drugs are the most common treatment for depressive episodes but only a fraction of patients experience adequate response. Here the authors find dysregulation of miRNAs in peripheral blood samples from depressed patients after antidepressant treatment, and show that the miRNAs are regulators of psychiatrically relevant signalling pathways.